ASX:TLXPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Telix Pharmaceuticals Ltd
$14.510
+$0.360 (+2.54%)
Day Range
$14.040 – $14.600
52 Week Range
$8.260 – $26.090
Volume
641.44K
Avg Volume (10D)
2.50M
Market Cap
$4.92B
Price Chart
Market Statistics
Open$14.130
Previous Close$14.150
Day High$14.600
Day Low$14.040
52 Week High$26.090
52 Week Low$8.260
Valuation
Market Cap4.92B
Shares Outstanding339.38M
Price to Book7.99
Trading Activity
Volume641.44K
Value Traded9.22M
Bid$14.510 × 168
Ask$14.520 × 866
Performance
1 Day0.44%
5 Day3.44%
13 Week18.38%
52 Week-45.90%
YTD23.66%
Technical Indicators
RSI (14)60.62
50-Day SMA$14.237
200-Day SMA$13.316
Latest News
Biotechnology
Five New Stocks For The Healthcare Sector Rotation: PME, TLX, TNE, 360, and SDR
ASX healthcare rotation heats up as PME, TLX, TNE, 360, SDR emerge—five stocks positioned to ride the sector shift amid oil, inflation and volatility.
Hot Topics
SmallCaps Weekly Wrap & New Fundie Picks
Hot Topics
Weekly Wrap: Strong Week Despite Late Fade
ASX up 4.4% for the week; strongest since Oct 2022, despite Friday fade. Magellan-Barrenjoey merger approved; Telix jumps on US regulator nod; Iran talks ahead.
ASX 200
Telix Pharmaceuticals to acquire Canadian isotope innovator ARTMS in $125.9m deal
Australian biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) is set to acquire Canadian radioisotope technology firm ARTMS Inc in a $125.9 million deal designed to boost its supply chain and production capacity. The deal will include ARTMS’ advanced cyclotron-based isotope production platform, a manufacturing plant and a stockpile of ultra-pure rare metals required for consumable target […]